Cargando…
Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses
Crimean-Congo Haemorrhagic Fever (CCHF) is a severe tick-borne disease, endemic in many countries in Africa, the Middle East, Eastern Europe and Asia. There is no approved vaccine currently available against CCHF. The most promising candidate, which has previously been shown to confer protection in...
Autores principales: | Dowall, Stuart D., Graham, Victoria A., Rayner, Emma, Hunter, Laura, Watson, Robert, Taylor, Irene, Rule, Antony, Carroll, Miles W., Hewson, Roger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896484/ https://www.ncbi.nlm.nih.gov/pubmed/27272940 http://dx.doi.org/10.1371/journal.pone.0156637 |
Ejemplares similares
-
Development of vaccines against Crimean-Congo haemorrhagic fever virus
por: Dowall, Stuart D., et al.
Publicado: (2017) -
A Novel Vaccine against Crimean-Congo Haemorrhagic Fever Protects 100% of Animals against Lethal Challenge in a Mouse Model
por: Buttigieg, Karen R., et al.
Publicado: (2014) -
Crimean-Congo haemorrhagic fever
por: Ergönül, Önder
Publicado: (2006) -
Adenoviral vectored vaccination protects against Crimean-Congo Haemorrhagic Fever disease in a lethal challenge model
por: Saunders, Jack E., et al.
Publicado: (2023) -
Serological and Virological Evidence of Crimean-Congo Haemorrhagic Fever Virus Circulation in the Human Population of Borno State, Northeastern Nigeria
por: Bukbuk, David N., et al.
Publicado: (2016)